The Australian federal court ruled that Nurofen’s varieties for back pain, period pain, migraine pain and tension headaches were all found to feature the same active ingredient, 342
Patients with ALS fatal neurodegenerative disorder suffer progressive degeneration of the motor neurons, which leads to a declining quality of life and even could lead to death, the
Vistogard is claimed to be the first antidote for emergency treatment of 5-fluorouracil (5-FU) overdose treatment available to patients. It is also indicated for patients exhibiting early-onset, severe
Reslizumab is a humanized IgG4K monoclonal antibody that binds to anti interleukin 5 (IL-5). The FDA will consider the advisory committee’s recommendation in its review of the biologics
Merck will provide funding and clinical supplies of pembrolizumab for the investigator-initiated study, which is anticipated to start in the first quarter of next year. Imprime PGG is
Syncona, an independent subsidiary of the Wellcome Trust, will invest £25m in a Series A financing. UCL professor of haematology Amit Nathwani developed Freeline's next-generation AAV gene therapy
DMD is a rare form of muscular dystrophy that leads to progressive and debilitating weakening of muscles in young males. It occurs due to mutations in the gene
ALLN-177 is designed to treat secondary hyperoxaluria in patients with a history of calcium oxalate kidney stones. Partner Fund Management led the Series C financing round, which included
The first study, Javelin Gastric 100, will compare the switch from first-line chemotherapy to maintenance therapy with avelumab versus continuation of chemotherapy. It will evaluate the potential superiority
LAL-D is caused by genetic mutations that lead to a marked decrease or loss in LAL enzyme activity in the lysosomes across several body tissue. Kanuma reduces substrate
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.